Study Summary
This trial aims to understand experiences unique to transgender men who have sex with men and how they affect HIV risk.
Eligible Conditions
- Human Immunodeficiency Virus (HIV) Infection
- Transgender
Treatment Effectiveness
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: up to 9 months
up to 9 months
Post-hoc thematic analysis across five domains
Trial Safety
Trial Design
0 Treatment Group
30 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 9 months
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,477 Previous Clinical Trials
811,027 Total Patients Enrolled
Eligibility Criteria
Age 18+ · Female Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You were identified as a girl when you were born.
You identify as a trans man or transmasculine.
You can use the Internet.
You identify as something other than heterosexual.